Clinical trial
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in…
NCT00000375 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00000375 |
|---|---|
| Title | Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder |
| Official title | Continuation ECT Vs Pharmacotherapy--Efficacy And Safety |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Behavioral, Drug, Procedure |
| Interventions | Nortriptyline-lithium (NOR-Li), Bilateral electroconvulsive therapy (ECT), Continuation therapy, Continuation ECT |
| Start date | Feb 1, 1997 |
| First posted | Nov 3, 1999 |
| Last update posted | Dec 20, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: